logo
The Steering Committee
Alastair Carruthers, MD, FRCP(C)
Site Disclaimer
eHealthcare Leadership Awards 2007 Winner
You need to upgrade your Flash Player
You need to upgrade your Flash Player to view this content.

What's New

• Environmental effects on skin aging, potential adverse events of onabotulinumtoxinA
Our newest slides explore the effects of environmental factors, including skin cancer history and smoking, on skin aging. We also explore a study of the safety and tolerability of onabotulinumtoxinA for facial lines.

• FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed
The FDA announced an update to a previous safety alert on four botulinum toxin drug products, noting that all of them now have boxed warnings on their labels and have developed Medication Guides for patients, as directed by the agency in April 2009. More here.

• FDA Requires Boxed Warning for Botulinum Toxin Products
The FDA has notified the manufacturers of licensed botulinum toxin products of the need to strengthen warnings in labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected. The FDA also urges manufacturers to develop and implement a Risk Evaluation and Mitigation Strategy (REMS) to ensure that product benefits outweigh risk.

• FDA Warning Letter Sent for Bimatoprost Ophthalmic Solution (Latisse™)
The FDA issued a warning letter to Allergan, Inc., manufacture of the eyelash enhancer, bimatoprost ophthalmic solution (Latisse™), for minimizing risks associated with the product's use. More here.

Slides of the Month

 

In The News

BioTime Reports Results From Independent Hextend(R) Study
Feb 08, 2010 -- BioTime, Inc. (NYSE Amex:BTIM) reported recently-released results from an independent study evaluating the use of Hextend in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume)...
Bacteria Toxic To Wound-Treating Maggots
Feb 06, 2010 -- Bacteria that infect chronic wounds can be deadly to maggot 'biosurgeons' used to treat the lesions, show researchers writing in the journal Microbiology. The findings could lead to more effective treatment of wounds and the development of novel antibiotics...
First Fractional Laser FDA Cleared For Striae
Feb 05, 2010 -- Palomar Medical Technologies, Inc. is pleased to announce that the Lux1540 Fractional non-ablative laser handpiece has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretch marks) using a fractional laser...
First Fractional Laser FDA Cleared For Striae
Feb 05, 2010 -- Palomar Medical Technologies, Inc. is pleased to announce that the Lux1540 Fractional non-ablative laser handpiece has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretch marks) using a fractional laser...
Copyright 2007 Medical News Today
Login
Username:
Password:
Register
Forgot Password?
Ask the Expert
Have a question for one of our experts?
Submit it here

View all Questions

Participate in our
Online polls
How is bimatoprost ophthalmic solution (Latisse) integrated into treatment regimens in your practice?



Upcoming Events